Panagora Asset Management’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,241
Closed -$33K 2660
2019
Q2
$33K Sell
3,241
-238
-7% -$2.7K ﹤0.01% 2186
2019
Q1
$49K Hold
3,479
﹤0.01% 2044
2018
Q4
$55K Sell
3,479
-66
-2% -$1.14K ﹤0.01% 1945
2018
Q3
$67K Sell
3,545
-2,435
-41% -$48.5K ﹤0.01% 1964
2018
Q2
$115K Sell
5,980
-99
-2% -$2.01K ﹤0.01% 1810
2018
Q1
$126K Hold
6,079
﹤0.01% 1797
2017
Q4
$125K Sell
6,079
-157
-3% -$2.91K ﹤0.01% 1818
2017
Q3
$115K Buy
6,236
+4,296
+221% +$94.6K ﹤0.01% 1859
2017
Q2
$48K Buy
1,940
+1,097
+130% +$23.1K ﹤0.01% 2082
2017
Q1
$17K Buy
+843
New +$18.5K ﹤0.01% 2209

Other funds holding PMD

Panagora Asset Management's PMD Position: Q3 2019 in Review

Panagora Asset Management sold out of Psychemedics Corporation (PMD) in Q3 2019, closing a stake of 3,241 shares — an estimated $33K sold.

Panagora Asset Management first reported a position in PMD in Q1 2017 and held it in 10 quarters. The position peaked at $126K in Q1 2018. 45 funds tracked by Wall St. Rank hold PMD as of Q3 2019.

  • Panagora Asset Management reported no remaining Psychemedics Corporation position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 3,241 Psychemedics Corporation shares in Q3 2019, an estimated $33K.
  • Panagora Asset Management first reported a position in Psychemedics Corporation in Q1 2017 and held it in 10 quarters.
  • Panagora Asset Management's Psychemedics Corporation position peaked at $126K in Q1 2018.
  • 45 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.